| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.417 | 0 | 29.889 | 33.128 | 41.851 | 41.072 | 36.185 | 41.367 | 43.660 | 8.041 |
| Total Income - EUR | 1.417 | 0 | 29.966 | 33.128 | 41.909 | 41.191 | 36.204 | 41.422 | 43.660 | 16.083 |
| Total Expenses - EUR | 1.324 | 2.896 | 10.053 | 11.502 | 12.167 | 18.551 | 11.550 | 15.666 | 12.674 | 8.546 |
| Gross Profit/Loss - EUR | 93 | -2.896 | 19.912 | 21.626 | 29.742 | 22.640 | 24.654 | 25.756 | 30.986 | 7.537 |
| Net Profit/Loss - EUR | 13 | -2.896 | 16.139 | 20.632 | 28.485 | 21.408 | 23.589 | 24.664 | 25.309 | 6.070 |
| Employees | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Panmedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.497 | 743 | 570 | 402 | 27.047 | 24.145 | 19.426 | 14.468 | 8.940 | 6.632 |
| Current Assets | 1.469 | 40 | 12.496 | 30.843 | 14.967 | 34.004 | 35.284 | 42.456 | 17.927 | 16.088 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 259 | 0 | 0 | 0 |
| Receivables | 1.417 | 0 | 2.474 | 2.471 | 12.046 | 12.194 | 11.923 | 12.468 | 9.763 | 8.943 |
| Cash | 52 | 40 | 10.022 | 28.372 | 2.921 | 21.810 | 23.102 | 29.989 | 8.164 | 7.145 |
| Shareholders Funds | -2.184 | -5.058 | 11.167 | 31.594 | 30.385 | 51.217 | 32.176 | 56.940 | 27.132 | 19.109 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.150 | 5.840 | 1.899 | 272 | 12.152 | 7.264 | 22.948 | 162 | 61 | 3.817 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Panmedica S.r.l.